01 1Viatris
01 1TENOFOVIR ALAFENAMIDE FUMARATE
01 1U.S.A
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2016-03-03
Pay. Date : 2015-11-24
DMF Number : 30013
Submission : 2015-12-24
Status : Active
Type : II
20
Matrix Pharmacorp Private Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is TENOFOVIR ALAFENAMIDE FUMARATE, with a corresponding US DMF Number 30013.
Remarkably, this DMF maintains an Active status since its submission on December 24, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 03, 2016, and payment made on November 24, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II
